BioXcel collaborates with Merck KGaA and Pfizer to study avelumab with BXCL-701 and NKTR-214 March 5, 2019
CARB-X funding to support Contrafect's development of amurins to treat Gram-negative pathogens March 5, 2019
Healx partners with Boston Children's Hospital to advance drug discovery in Barth syndrome March 4, 2019
Apellis enters collaboration with SFJ Pharmaceuticals for APL-2 in hematologic indications March 1, 2019
RSS